BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Derebail VK, Rheault MN, Kerlin BA. Role of direct oral anticoagulants in patients with kidney disease. Kidney Int 2020;97:664-75. [PMID: 32107019 DOI: 10.1016/j.kint.2019.11.027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Wada R, Shinohara M, Nakanishi R, Kinosihita T, Yuzawa H, Ikeda T. Relationship between the degree of renal dysfunction and the safety and efficacy outcomes in patients with atrial fibrillation receiving direct oral anticoagulants. J Arrhythm 2021;37:88-96. [PMID: 33664890 DOI: 10.1002/joa3.12493] [Reference Citation Analysis]
2 Munir MB, Khan MZ, Darden D, Nishimura M, Vanam S, Pasupula DK, Asad ZUA, Bhagat A, Zahid S, Osman M, Balla S, Han FT, Reeves R, Hsu JC. Association of chronic kidney disease and end-stage renal disease with procedural complications and in-hospital outcomes from left atrial appendage occlusion device implantation in patients with atrial fibrillation: Insights from the national inpatient sample of 36,065 procedures. Heart Rhythm O2 2021;2:472-9. [PMID: 34667962 DOI: 10.1016/j.hroo.2021.08.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ording AG, Søgaard M, Skjøth F, Grove EL, Lip GYH, Larsen TB, Nielsen PB. Hematuria in anticoagulated patients with atrial fibrillation and urologic cancer. Res Pract Thromb Haemost 2022;6. [DOI: 10.1002/rth2.12629] [Reference Citation Analysis]
4 Eikelboom J, Floege J, Thadhani R, Weitz JI, Winkelmayer WC. Anticoagulation in patients with kidney failure on dialysis: factor XI as a therapeutic target. Kidney Int 2021;100:1199-207. [PMID: 34600964 DOI: 10.1016/j.kint.2021.08.028] [Reference Citation Analysis]
5 Waller AP, Agrawal S, Wolfgang KJ, Kino J, Chanley MA, Smoyer WE, Kerlin BA; Pediatric Nephrology Research Consortium (PNRC). Nephrotic syndrome-associated hypercoagulopathy is alleviated by both pioglitazone and glucocorticoid which target two different nuclear receptors. Physiol Rep 2020;8:e14515. [PMID: 32776495 DOI: 10.14814/phy2.14515] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Tran L, Pannier B, Lacolley P, Serrato T, Benetos A, London GM, Bézie Y, Regnault V. A case-control study indicates that coagulation imbalance is associated with arteriosclerosis and markers of endothelial dysfunction in kidney failure. Kidney Int 2021;99:1162-72. [PMID: 33359501 DOI: 10.1016/j.kint.2020.12.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Waller AP, Troost JP, Parikh SV, Wolfgang KJ, Rovin BH, Nieman MT, Smoyer WE, Kretzler M, Kerlin BA; NEPTUNE Investigators. Nephrotic syndrome disease activity is proportional to its associated hypercoagulopathy. Thromb Res 2021;201:50-9. [PMID: 33636573 DOI: 10.1016/j.thromres.2021.02.007] [Reference Citation Analysis]
8 Toorop MMA, Scheres LJJ, Lijfering WM. The relationship between DOAC levels and clinical outcomes: The measures tell the tale-Response from original authors Lijfering et al. J Thromb Haemost 2021;19:1136-8. [PMID: 33792178 DOI: 10.1111/jth.15248] [Reference Citation Analysis]
9 Toorop MMA, Lijfering WM, Scheres LJJ. The relationship between DOAC levels and clinical outcomes: The measures tell the tale. J Thromb Haemost 2020;18:3163-8. [PMID: 32979033 DOI: 10.1111/jth.15104] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]